PETV (PetVivo Holdings) Forward Dividend Yield %: 0.00% (As of Jul. 06, 2026)


PETV PetVivo Holdings Inc PETV
31 GF Score
Price $0.80
GF Value $0.51
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is PetVivo Holdings Forward Dividend Yield %?

PetVivo Holdings PETV -4.65% 31 Forward Dividend Yield % is 0.00% as of Jul. 06, 2026. GuruFocus rates PETV with a GF Score™ of 31/100 and a GF Value™ of $0.51 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 314 Medical Devices & Instruments companies, PetVivo Holdings ranks worse than 318471.02% on this metric.

As of today (2026-07-06), the Forward Annual Dividend Yield of PetVivo Holdings is 0.00%.

As of today (2026-07-06), the Trailing Annual Dividend Yield of PetVivo Holdings is 0.00%.

PETV's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.085
* Ranked among companies with meaningful Forward Dividend Yield % only.

PetVivo Holdings's Dividends per Share for the three months ended in Mar. 2026 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


PetVivo Holdings  (OTCPK:PETV) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


PetVivo Holdings Forward Dividend Yield % Related Terms


PETV vs ARAY, RDGL, NSPR: Forward Dividend Yield % Comparison

For the Medical Devices subindustry, PetVivo Holdings's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PetVivo Holdings Forward Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where PetVivo Holdings's Forward Dividend Yield % falls into.


PETV
31GF Score
PetVivo Holdings Inc PETV
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PetVivo Holdings Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
PetVivo Holdings (PETV) has a Forward Dividend Yield % of 0.00% as of Jul. 06, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on PetVivo Holdings and its competitors. According to the industry distribution chart, PetVivo Holdings ranks #999999 out of 314 companies in the Medical Devices & Instruments industry.
Is PetVivo Holdings' Forward Dividend Yield % too high?
PetVivo Holdings' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, PetVivo Holdings ranks #999999 out of 314 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PetVivo Holdings has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PetVivo Holdings' Forward Dividend Yield % compare to ARAY and RDGL?
According to the Medical Devices & Instruments industry distribution chart, PetVivo Holdings ranks #999999 out of 314 companies for Forward Dividend Yield %. This places PetVivo Holdings in the lower half of its industry. The industry median Forward Dividend Yield % is 2.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.09, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on PetVivo Holdings and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PetVivo Holdings's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetVivo Holdings stock overvalued right now?
Based on GuruFocus' analysis, PetVivo Holdings (PETV) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.51, compared to a current price of $0.80 — trading 56.9% above its estimated fair value. The current Forward Dividend Yield % is 0.00%. PetVivo Holdings' overall GF Score™ is 31/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For PetVivo Holdings (PETV), the current Forward Dividend Yield % is 0.00% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PetVivo Holdings (PETV) Overvalued in 2026?

Based on GuruFocus' analysis, PetVivo Holdings stock appears to be overvalued. The current stock price of $0.80 is trading 56.9% above its estimated GF Value™ of $0.51. GuruFocus considers PetVivo Holdings to be Significantly Overvalued.

Key valuation signals for PETV:

  • Forward Dividend Yield %: 0.00%
  • GF Value™: $0.51 vs. price of $0.80 (56.9% above fair value)
  • GF Score™: 31/100 with 6 warning signs

No single metric tells the full story. See the PETV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PetVivo Holdings Business Description

Address 5151 Edina Industrial Boulevard, Suite 575, Edina, MN, USA, 55439
PetVivo Holdings Inc is an emerging biomedical device company. It is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of several patents. The company has also begun the commercialization of its product Spryng with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses.
31GF Score

Get the complete analysis for PETV

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.80
Price
$0.51
GF Value